Exactech was issued U.S. Patent #11,278,338 for the Newton™ Knee, a platform of technology that is used with implants that are designed to provide optimal balance in a reproducible way.
The Newton Knee is in pilot release, with limited launch planned for later this year.
The patent recognizes Newton’s approach to providing critical soft tissue data that helps orthopedic surgeons execute a total knee replacement with precision. Newton captures active balance data through the entire arc of motion with the patella in place, and seamlessly integrates with ExactechGPS® for visualization of a predictive plan through quantifiable insights.
“The patent allowance supports the uniqueness of Newton and its ability to maintain a force-controlled environment regardless of the joint gap through antagonist sub-mechanisms,” said Laurent Angibaud, Vice President of Advanced Surgical Technologies at Exactech. “While initially dedicated to total knee arthroplasty, Newton has the potential to be applied to other joints where proper soft tissue management is of paramount importance.”
Exactech was issued U.S. Patent #11,278,338 for the Newton™ Knee, a platform of technology that is used with implants that are designed to provide optimal balance in a reproducible way.
The Newton Knee is in pilot release, with limited launch planned for later this year.
The patent recognizes Newton’s approach to providing critical soft...
Exactech was issued U.S. Patent #11,278,338 for the Newton™ Knee, a platform of technology that is used with implants that are designed to provide optimal balance in a reproducible way.
The Newton Knee is in pilot release, with limited launch planned for later this year.
The patent recognizes Newton’s approach to providing critical soft tissue data that helps orthopedic surgeons execute a total knee replacement with precision. Newton captures active balance data through the entire arc of motion with the patella in place, and seamlessly integrates with ExactechGPS® for visualization of a predictive plan through quantifiable insights.
“The patent allowance supports the uniqueness of Newton and its ability to maintain a force-controlled environment regardless of the joint gap through antagonist sub-mechanisms,” said Laurent Angibaud, Vice President of Advanced Surgical Technologies at Exactech. “While initially dedicated to total knee arthroplasty, Newton has the potential to be applied to other joints where proper soft tissue management is of paramount importance.”
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
